INTERLEUKIN
Clinical trials for INTERLEUKIN explained in plain language.
Never miss a new study
Get alerted when new INTERLEUKIN trials appear
Sign up with your email to follow new studies for INTERLEUKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called IL-22BP/LNP in people with advanced solid tumors (like sarcoma, head and neck cancer, or melanoma) that have not responded to standard treatments. The main goals are to check the drug's safety and see if it can shrink tumors. Only 6 …
Matched conditions: INTERLEUKIN
Phase: PHASE1 • Sponsor: Xingchen Peng • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New hope for Hard-to-Treat cancers: early trial of IL-22BP begins
Disease control Recruiting nowThis early-stage trial tests a new drug called IL-22BP in about 6 adults with advanced solid tumors that have not responded to at least two prior treatments. The main goals are to check the drug's safety and find the right dose, while also seeing if it can shrink tumors. The stud…
Matched conditions: INTERLEUKIN
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC